The INHALE team is excited to announce the launch of our online formulary tool! With this interactive tool, you could search coverage by plan type, and narrow down options by[…]
News
Michigan experienced unhealthy air quality during the week of July 13, 2026. More poor air quality is expected because of ongoing wildfires in the United States and Canada, along with[…]
Patients with uncontrolled type 2 asthma may underreport symptoms, normalize limitations, or mask poor control through daily workarounds. Fortunately, patient education, open-ended questioning, active listening, and structured tools like symptom[…]
Throughout Michigan, the air that we breathe may not be all that we need, based on the latest State of the Air report from the American Lung Association. Wayne and[…]
AstraZeneca’s press release announces that the FDA has approved Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) as the first and only single‑inhaler triple‑combination maintenance therapy for asthma in patients 12 years and older[…]
HEAL (Health Equity Advancement & Leadership) is a project with the goal of building and supporting community-based work to address inequities in asthma. The overall goal of HEAL is to[…]
The Asthma and Allergy Foundation of America (AAFA) has published a new resource: “Health Insurance Marketplace Guide for Asthma and Allergies for 2026.” This comprehensive guide is designed to help[…]
Looking to help yourself or others quit tobacco for good? The Michigan Department of Health and Human Services (MDHHS) Tobacco Cessation Toolkit offers comprehensive resources for individuals and organizations supporting[…]
As anti-inflammatory rescue therapies begin making their way to patients with asthma, new questions about implementation of this life-saving therapy are emerging, prompting more exciting research from scientists and clinicians.[…]
In this American Medical Journal interview, Njira Lugogo, MD, Monica Kraft, MD, and Reynold A. Panettieri, Jr, M.D talk about rethinking mild asthma in primary care, the BATURA trial results,[…]